Director Trades
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cochlear.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: Quality names continue to catch a bid as earnings roll in
News
Here are the top ASX large cap movers for Friday
Health & Biotech
ASX Health Stocks: Chimeric gets FDA clearance, Cochlear posts record sales
News
Market Highlights and 5 ASX Small Caps to watch on Friday
Health & Biotech
This ASX-listed healthcare ETF returned 33pc in 2020 – and it’s not Blackrock’s IXJ
News
Here are the top ASX large cap movers for Friday
Experts
MoneyTalks: Could this ASX medtech stock become the next Cochlear?
Experts
ScoPo’s health powerplays: What to look for this earnings season
Experts
ScoPo’s health powerplays: ‘We’re buying any pullbacks’
Experts
Scopo’s powerplays: Investors love a result, until they don’t
Health & Biotech
The healthcare winners and losers after COVID-19, and what comes next
Health & Biotech
We’re still here: investors keen on health despite market shun
Experts
ScoPo’s health powerplays: Ramp ups and turnaround favs
Experts
ScoPo’s health powerplays: Cap raises goin’ crazy
Experts
This fund manager suggests investors need to look for businesses that will ‘always be there’
Health & Biotech
Check up: Is anyone making non-COVID-19 money these days? Actually, yes
News
